AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $76.15M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.15pm 30/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 6.3¢ | Day High | 6.3¢ | Day Low | 5.9¢ | |||
| Daily Volume | 1224504 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 5.9¢ | 21583 | 0 | 6.2¢ | 90000 | |
Directors & Senior Management
| Prof. Anastasios Karadimitris | Chairman of Scientific Advisory Board |
| Dr. Cameron J. Turtle | Member of Clinical Advisory Board |
| Mr. David John Williams | Non-Executive Chairman |
| Dr. Debora Barton | Member of Clinical Advisory Board |
| Dr. Gianpietro Dotti | Member of Scientific Advisory Board |
| Dr. John Maher | Member of Scientific Advisory Board |
| Mr. Lachie Mallia | CFO & Company Secretary |
| Mr. Mark Diamond | Non-Executive Director |
| Dr. Michael Joseph Thurn | Non-Executive Director |
| Dr. Michelle Ferguson | Senior Director of Research & Development |
| Ms. Michelle Long | Administration Manager |
| Dr. Nicole van der Weerden | Acting Chief Executive Officer |
| Dr. Reuben Benjamin | Member of Scientific Advisory Board |
| Dr. Robson Dossa | Senior Vice President of Manufacturing & Quality |
| Dr. Sattva S. Neelapu | Member of Clinical Advisory Board |
Data source: ADVFN
